The Lipitor Warning for GLP-1 Drugmakers
By Joe Renny
March 23, 2026
Pfizer’s Lipitor experience shows the structural risks that today’s GLP-1 innovators may soon face
7 min read
False
Advertisement
Development & Clinical
saRNA Injection Targets Cardiac Injury
March 17, 2026
Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction
1 min read
Armoring CAR-T Against Solid Tumors
March 17, 2026
UCLA researchers create armored CAR-T cells that show promise for treating solid tumors
2 min read
Why Copilots Failed in R&D and What Comes Next
By Yiannis Kiachopoulos
March 16, 2026
Organizations that benefit most from AI in R&D will be those that align technology with scientific reality
4 min read
Breaking the Size Barrier in CAR T Engineering
March 16, 2026
An optimized workflow increases lentiviral delivery efficiency for large CAR constructs
1 min read
T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy
March 16, 2026
The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers
2 min read
Building Quality into Advanced Therapies from Day One
March 13, 2026
Why early, risk-based thinking is critical in cell and gene therapy development
5 min read
Precision Therapies: The Last Mile
By Pete Harbin
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
Accelerating Structure-based Drug Design for Complex Membrane Proteins
March 9, 2026
Nuclera and leadXpro partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets
2 min read
The Strategic Role of CRA AI Agents in Clinical Research
By Andrew Mackinnon
March 6, 2026
Using agentic AI to reduce clinical trial inefficiency
7 min read
